It can promote the apoptosis of GC cells and inhibit GCLM by downregulating the expression of HIF-1α, PI3K, and p-AKT proteins in the PI3K/AKT signaling pathway mediated by HIF-1α104. The gene discussed is AKT1; the disease is gastric cancer.